Two Sigma Investments’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Two Sigma Investments's INMB Position: Q3 2026 in Review
Two Sigma Investments opened a new position in INmune Bio (INMB) in Q3 2026: 10,366 shares worth $20.2K. The stake represents ﹤0.01% of the portfolio and ranks #4800 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in INMB as recently as Q2 2025.
Two Sigma Investments first reported a position in INMB in Q3 2024 and has held it in 5 quarters since. The position peaked at $310K in Q4 2024. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.
- Two Sigma Investments held 10,366 shares of INmune Bio worth $20.2K as of Q3 2026.
- INmune Bio was a new Two Sigma Investments position in Q3 2026.
- INmune Bio made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #4800 holding.
- Two Sigma Investments first reported a position in INmune Bio in Q3 2024 and has held it in 5 quarters since.
- Two Sigma Investments's INmune Bio position peaked at $310K in Q4 2024.
- 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.